GAFFX
Price
$77.91
Change
-$0.26 (-0.33%)
Updated
Jun 5 closing price
Net Assets
305.91B
RGACX
Price
$75.11
Change
-$0.25 (-0.33%)
Updated
Jun 5 closing price
Net Assets
305.91B
Interact to see
Advertisement

GAFFX vs RGACX

Header iconGAFFX vs RGACX Comparison
Open Charts GAFFX vs RGACXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.91
Change-$0.26 (-0.33%)
VolumeN/A
Net Assets305.91B
American Funds Growth Fund of Amer R3
Price$75.11
Change-$0.25 (-0.33%)
VolumeN/A
Net Assets305.91B
GAFFX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. RGACX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX (306B) and RGACX (306B) have equal amount of cash in the bank . GAFFX pays higher dividends than RGACX: GAFFX (0.65) vs RGACX (0.08). GAFFX was incepted earlier than RGACX: GAFFX (8 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than GAFFX (0.30). GAFFX (25.00) and RGACX (25.00) have comparable annual turnover. RGACX has a lower initial minimum investment than GAFFX: RGACX (250) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.03 vs. RGACX (8.05). GAFFX return over 5 years is better than : 46.12 vs. RGACX (41.96).
GAFFXRGACXGAFFX / RGACX
Total Expense Ratio0.300.9432%
Annual Report Gross Expense Ratio0.300.9432%
Fund Existence8 years23 years-
Gain YTD4.9684.681106%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets306B306B100%
Annual Yield % from dividends0.650.08834%
Returns for 1 year9.038.05112%
Returns for 3 years38.8636.40107%
Returns for 5 years46.1241.96110%
Returns for 10 yearsN/A70.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYMR47.663.40
+7.68%
Kymera Therapeutics
PMCB1.120.03
+2.29%
PharmaCyte Biotech
GFI25.420.38
+1.52%
Gold Fields Ltd
RMAX7.610.03
+0.40%
Re/Max Holdings
CLW29.40-0.21
-0.71%
Clearwater Paper Corp